- Contractors
- The Institute for Cancer Research
The Institute for Cancer Research
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
The Institute for Cancer Research has 6 federal contracts of $100,000 or more active since October 2023, with $7.26M obligated, from 1 agency. 4 are still running, 4 ending within 18 months.
- Contracts
- 6 since FY2024$7,255,309 obligated, contracts of $100,000 or more
- Running now
- 4 contracts1 ended in the last 12 months
- Biggest customer
- National Institutes of Health$7.26M on 6 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- FF1XVJMDYVR1Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2020 | $779,932 |
| FY2022 | $4,237,145 |
| FY2023 | $2,238,232 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Task Order Title: Next Generation GP130/Il-6/STAT3 Inhibitors for the Prevention of Colitis-Associated Colorectal CancerNational Institutes of Health · 75N91022F00002 | $1,237,620 | Nov 17, 2026within a month | PA |
| Prevent Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarkers Task Order Title: Sulforaphane for the Prevention of Malignant MesotheliomaNational Institutes of Health · 75N91023F00003 | $1,199,274 | May 2, 2027in 5 months | PA |
| Base Title: Prevent Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomakers Task Order Title: Vaccines Against Fusobacterium for Fap-and Lynch…National Institutes of Health · 75N91022F00001 | $2,051,148 | May 14, 2027in 5 months | PA |
| Colorectal Cancer (Crc) Prevention by Urolithin a in Rodent Crc ModelsNational Institutes of Health · 75N91023F00001 | $1,038,958 | Jul 9, 2027in 7 months | PA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health6 contracts | $7,255,309 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 6 contracts | $7,255,309 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Pennsylvania6 contracts | $7,255,309 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like The Institute for Cancer Research's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy